• Wiley Online Library will be disrupted on 26 May from 10:00-12:00 BST (05:00-07:00 EDT) for essential maintenance

Chapter 10. Drug Treatment: Memantine

  1. Alistair Burns3,
  2. Bengt Winblad4
  1. Anton P. Porsteinsson1,
  2. Pierre N. Tariot2

Published Online: 19 SEP 2006

DOI: 10.1002/0470010568.ch10

Book Title

Severe Dementia

Severe Dementia

Additional Information

How to Cite

Porsteinsson, A. P. and Tariot, P. N. (2006) Drug Treatment: Memantine, in Severe Dementia (eds A. Burns and B. Winblad), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470010568.ch10

Editor Information

  1. 3

    Department of Old Age Psychiatry, University of Manchester, Education and Research Centre, Wythenshawe Hospital, Manchester M23 9Lt, UK

  2. 4

    Division of Geriatric Medicine, Karolinska Institute, Neurotec B 84, Karolinska University Hospital, SE-14186 Stockholm, Sweden

Author Information

  1. 1

    University of Rochester School of Medicine & Dentistry, Monroe Community Hospital, 435 East Henrietta Road, Rochester, NY 14620, USA

  2. 2

    Psychiatry Unit, Monroe Community Hospital, 435 East Henrietta Road, Rochester, NY 14620, USA

Publication History

  1. Published Online: 19 SEP 2006
  2. Published Print: 21 APR 2006

ISBN Information

Print ISBN: 9780470010549

Online ISBN: 9780470010563

SEARCH

CHAPTER TOOLS

Get PDF (230K)

Keywords:

  • drug treatment with memantine;
  • memantine in acute excitotoxic damage;
  • cholinesterase inhibitors in mild-to-moderate AD;
  • memantine in moderate-to-severe Alzheimer's disease;
  • European Medicines Agency (EMEA)

Summary

This chapter contains sections titled:

  • Introduction

  • Possible role of glutamate in AD

  • Memantine

  • Pivotal clinical trials

  • Conclusion

  • References

Get PDF (230K)